Letter to the editor [2]

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 604-605

  McLendon, Roger E ^a   Rasheed, Ahmed ^a   Wiltshire, Rodney ^a   Herndon, James ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ASTROCYTOMA; CANCER CLASSIFICATION; CELL ULTRASTRUCTURE; CENTROMERE; CHROMATIN; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ARM; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG SENSITIVITY; FOLLOW UP; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; LETTER; MICROSCOPY; PRIORITY JOURNAL; RADIOSENSITIVITY; TELOMERE; BRAIN TUMOR; CHROMOSOME 1; CHROMOSOME 19; CHROMOSOME DELETION; GENETICS; METABOLISM; NOTE; OLIGODENDROGLIOMA; PROGNOSIS;

ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; GLIOMA; HUMANS; OLIGODENDROGLIOMA; PROGNOSIS;

EID: 6944221790     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800077     Document Type: Letter

References (3)

1. Burger PC, Minn AY, Smith JC, et al. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Mod Pathol 2001;14:842-853.
2. Nutt CL, Noble M, Chambers AF, et al. Differential expression of drug resistance genes and chrmosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res 2000;60:4812-4818.
3. Bigner SH, Matthews MR, Rasheed BK, et al. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 1999;155:375-386.